Position in ABBV
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$1,636,414
+$291,674 QoQ
Shares Held
6,503
+5.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.48%
of 13F equity value
Holder Rank
#2,118
of 4,153 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Monument Capital Management holds $17,122,223 across 11 Drug Manufacturers - General names. ABBV ranks #4 (9.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
18,097 | $4,596,095 | |
| 2 | LLY |
ELI LILLY & Co
|
2,528 | $3,032,159 | |
| 3 | MRK |
Merck & Co., Inc.
|
22,665 | $2,912,452 | |
| 4 | ABBV |
AbbVie Inc.
This page
|
6,503 | $1,636,414 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
12,267 | $1,549,812 | |
| 6 | AMGN |
Amgen Inc
|
2,614 | $946,581 | |
| 7 | NVS |
Novartis AG
|
5,076 | $795,510 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
12,867 | $741,396 |
All Filings in ABBV
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,636,414 | 6,503 | Shares | Sole | 2026-07-22 | |
| 2026-03-31 | $1,344,740 | 6,183 | Shares | Sole | 2026-04-16 | |
| 2025-12-31 | $1,419,151 | 6,211 | Shares | Sole | 2026-01-26 | |
| 2025-09-30 | $1,438,094 | 6,211 | Shares | Sole | 2025-10-14 | |
| 2025-06-30 | $1,210,428 | 6,521 | Shares | Sole | 2025-07-24 | |
| 2025-03-31 | $1,373,403 | 6,555 | Shares | Sole | 2025-04-25 | |
| 2024-12-31 | $1,165,178 | 6,557 | Shares | Sole | 2025-01-31 | |
| 2024-09-30 | $1,294,678 | 6,556 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $1,124,656 | 6,557 | Shares | Sole | 2024-07-22 | |
| 2024-03-31 | $1,178,551 | 6,472 | Shares | Sole | 2024-04-19 | |
| 2023-12-31 | $1,015,363 | 6,552 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $1,104,385 | 7,409 | Shares | Sole | 2023-10-25 | |
| 2023-06-30 | $1,672,672 | 12,415 | Shares | Sole | 2023-07-18 | |
| 2023-03-31 | $2,810,489 | 17,635 | Shares | Sole | 2023-04-21 | |
| 2022-12-31 | $2,709,391 | 16,765 | Shares | Sole | 2023-01-27 | |
| 2022-09-30 | $1,762,311 | 13,131 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $1,969,637 | 12,860 | Shares | Sole | 2022-07-20 | |
| 2022-03-31 | $1,771,375 | 10,927 | Shares | Sole | 2022-04-14 | |
| 2021-12-31 | $1,469,631 | 10,854 | Shares | Sole | 2022-01-18 | |
| 2021-09-30 | $1,102,539 | 10,221 | Shares | Sole | 2021-10-22 | |
| 2021-06-30 | $1,106,575 | 9,824 | Shares | Sole | 2021-07-27 | |
| 2021-03-31 | $783,621 | 7,241 | Shares | Sole | 2021-04-12 | |
| 2020-12-31 | $792,588 | 7,397 | Shares | Sole | 2021-01-15 | |
| No filing history on record for this holder in this stock. | ||||||